OverviewSuggest Edit

Momenta is a company building software for autonomous vehicles. Its trained deep-learning engine locates the vehicles, pedestrians, and roads and positions them into a 3D reconstructed map in real time. The Company offers multi-level autonomous driving solutions as well as big data products and services.

Latest Updates

Employees (est.) (Oct 2021)337(+3%)
Job Openings208
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Momenta

Xudong Cao

Xudong Cao


Momenta Office Locations

Momenta has offices in Suzhou Shi and Stuttgart
Suzhou Shi, CN
Bei Tian Cheng Lu, Xiangcheng Qu
Stuttgart, DE
Rotebühlpl. 23
Show all (3)

Momenta Financials and Metrics

Summary Metrics

Founding Date


Momenta total Funding

$703 m

Momenta latest funding size

$500 m

Time since last funding

7 months ago

Momenta investors

Momenta's latest funding round in March 2021 was reported to be $500 m. In total, Momenta has raised $703 m. Momenta's latest valuation is reported to be $1 b.
View all funding rounds

Momenta Revenue

Market valuation

Show all financial metrics

Momenta Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Momenta Online and Social Media Presence

Embed Graph

Momenta News and Updates

Report: Autonomous driving firm Momenta nets $500m from SAIC, others

The new funds will be used to expand the company's workforce and help it gather data to improve future technologies.

J&J Borrows $7.5 Billion for Momenta in Latest M&A Bond Sale

J&J Kicks Off Bond Sale to Fund Year’s Biggest Pharma Deal

Is Momenta A Good Fit For JNJ?

The stock price of Momenta Pharmaceuticals, a pharmaceutical company best known for its immunology therapies, has rallied around 26% over recent weeks (vs. about a 50% gain in the S&P 500) to $31 as of August 18, after falling to a low of $24 in late March, when a rapid increase in the number...

(MNTA) Alert: Johnson Fistel Investigates Proposed Sale of Momenta Pharmaceuticals; Are Shareholders Getting a Fair Price?

SAN DIEGO, Aug. 19, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Momenta Pharmaceuticals, Inc. ("Momenta" or the "Company") (NASDAQ: MNTA) breached their fiduciary duties in connection with the...

J&J $6.5 Billion Momenta Pact Is Year’s Biggest Pharma Deal

Johnson & Johnson agreed to buy Momenta Pharmaceuticals Inc. for about $6.5 billion to expand in treatments for autoimmune disease
Show more

Momenta Frequently Asked Questions

  • When was Momenta founded?

    Momenta was founded in 2016.

  • Who are Momenta key executives?

    Momenta's key executives are Xudong Cao.

  • How many employees does Momenta have?

    Momenta has 337 employees.

  • Who are Momenta competitors?

    Competitors of Momenta include WeRide.ai, StradVision and PlusAI.

  • Where are Momenta offices?

    Momenta has offices in Suzhou Shi and Stuttgart.

  • How many offices does Momenta have?

    Momenta has 3 offices.